The pharmaceutical sector has a first-class trend today, and as of the time of publication, biomedicine has risen 085%, CSI Medical**023%, *, $Hengrui Pharmaceutical$+085%, $Zhifei Biotech$+12%, $Pharmaron $+35%, $WuXi AppTec$+15%, so what is the reason for the ** of the pharmaceutical sector?What's next?
Personally, I think the main reasons for the pharmaceutical sector are as follows:
First, the pharmaceutical sector fell significantly last week due to the negative impact of WuXi Biologics' downward revision, and was greatly repaired, and fell to near the October low this week to find support
Second, yesterday, the National Health Insurance Bureau announced that the adjustment of the national basic medical insurance, work-related injury insurance and maternity insurance drug catalogue in 2023 has been successfully concluded. The new catalogue will be implemented from January 1, 2024. At the same time, the National Health Insurance Bureau said that it will increase the tilt and support for innovative drugs, and improve the negotiation and renewal rules to support the development of innovative drugs, which is good for innovative drugs
Third, the US dollar fell sharply after the Federal Reserve announced a pause in interest rate hikes overnight, and the risk appetite of global markets increased
So on the whole, it is not surprising that the ** of today's pharmaceutical sector, at present, technically, biomedicine has been supported at the low point in October, but it has not yet broken through the 5th**, if the increase continues to expand in the afternoon, the volume can continue to increase It will basically stabilize, we continue to pay attention.
Below are some real-time estimates (updated to 11:30) for reference only.
Commonly used industry indices: $CSI Liquor$, Hang Seng Technology Index$, Semiconductor$, New Energy Vehicles$$, Game Animation$$Biomedicine$